WHA70: Statement of Knowledge Ecology International on antimicrobial resistance
On Wednesday, 24 May 2017, Knowledge Ecology International delivered the following intervention on antimicrobial resistance. This statement was read by Andrew Goldman.
SEC. 409K of the bill is titled, “PRIZE FUND FOR NEW AND MORE EFFECTIVE TREATMENTS OF BACTERIAL INFECTIONS.”
WHA70: Statement of Knowledge Ecology International on review of the GSPOA-PHI
On Friday, 26 May 2017, Knowledge Ecology International delivered the following intervention on the Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property. This statement was read by Manon Ress.
13.4 Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual propertyThe GSPOA evaluation conducted by Capra International was disappointing, raising questions about the terms of reference, and low ambition.
WHA70: Statement of Knowledge Ecology International: Review of the Pandemic Influenza Preparedness Framework
On Thursday, 25 May 2017, Knowledge Ecology International (KEI) delivered the following intervention on the Review of the Pandemic Influenza Preparedness Framework (PIP) at the 70th session of the World Health Assembly (WHA).
WHA70: Statement of Knowledge Ecology International on Research and development for potentially epidemic diseases
On Wednesday, 24 May 2017, Knowledge Ecology International delivered its maiden statement to the World Health Assembly on the topic of research and development for potentially epidemic diseases. The intervention was read by Diane Singhroy, PhD.
Seventieth World Health Assembly (A70/1)
Agenda Item: 12.1.3 Research and development for potentially epidemic diseasesRep. Jan Schakowsky Questions Dr. Anthony Fauci on Zika Vaccine Price at House Energy and Commerce Subcommittee Hearing
On May 23, 2017, Rep. Jan Schakowsky, D-Ill., asked Dr. Anthony Fauci whether he believed the federal government should use “every tool” to ensure that Sanofi charges a fair price for a taxpayer-funded Zika vaccine that is being developed by the U.S. Army and funded by BARDA.
Dr. Fauci responded that he did not believe that the government had the “mechanisms” to guarantee an affordable price, even when the U.S. government and taxpayers have made a “major investment” in the development of a drug.
KEI has separately uploaded a short clip of the exchange between Rep. Schakowsky and Dr. Fauci:
Additional information on the Army-BARDA-Sanofi vaccine collaboration is available at /zika and /zika-timeline.
Video of the full hearing and copies of written testimony are available via the House Energy and Commerce Committee website: https://energycommerce.house.gov/hearings-and-votes/hearings/us-public-health-response-zika-virus-continuing-challenges.
Groups ask Army to reconsider decision that would allow French firm to charge U.S. anything it wants on federally-funded vaccine
23 May 2017
Groups ask Army to reconsider decision that would allow French firm to charge the US anything it wants on a federally funded Zika vaccine
CONTACT: Zack Struver, zack.struver@keionline.org, +1 (914) 582-1428
Andrew Goldman, andrew.goldman@keionline.org
James Love, james.love@keionline.org, +1 (202) 361-3040WHA70 – Side Event on Addressing Access Barriers and Affordability Challenges for Cancer Drugs – 24 May 2017
On Wednesday, 24 May 2017, Knowledge Ecology International (KEI), Oxfam and Stichting Health Action International (HAI) are convening a side event on addressing access barriers and affordability challenges for cancer medicines. This panel will take place in Salle IX of the United Nations Palais des Nations from 18:00 to 19:30.
Date: Wednesday, 24 May 2017
Time: 18:00 to 19:30
Location: Salle IX, United Nations Palais des NationsPanelists:
Berlin Declaration of the G20 Health Ministers
After at least eight rounds of negotiation, including two Geneva-based negotiations held on 12 May 2017 and 17 May 2017, the G20 Health Ministers meeting, convened in Berlin from 19-20 May 2017 issued the following declaration.
In relation to the R&D pipeline for developing new antimicrobial therapies, the G20 recognized “the importance of fostering R&D for new antimicrobials, alternative therapies, vaccines and rapid-point-of care diagnostics, in particular for priority pathogens as identified by WHO and for tuberculosis.”
Louisiana Governor John Bel Edwards Asks U.S. Army to Require Sanofi to Charge Reasonable Price for Zika Vaccine
The Louisiana Governor John Bel Edwards asked the U.S. Army to require Sanofi to charge a reasonable price for a taxpayer-funded Zika vaccine, in a letter dated May 10, 2017.
SCCR 32: IFLA on Orphan Works
>> IFLA: Thank you again Mr. Chair for allowing IFLA to take the floor. IFLA supports initiatives to support and make available cumulative knowledge and cultural heritage and recognize the role of libraries and archives in that respect. We further… Continue Reading